Allspring Global Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-100,257	Closed	-$5.5M	–	1702
2025 Q3	$5.5M	Sell	100,257 -125	-0.1%	-$7.15K	0.01%	848
2025 Q2	$5.64M	Sell	100,382 -1,555	-2%	-$91.6K	0.01%	863
2025 Q1	$6.93M	Buy	101,937 +1,452	+1%	+$97.7K	0.01%	827
2024 Q4	$6.68M	Buy	100,485 +103	+0.1%	+$6.9K	0.01%	869
2024 Q3	$7.06M	Buy	100,382 +124	+0.1%	+$10.4K	0.01%	855
2024 Q2	$8.25M	Sell	100,258 -21	-0%	-$1.75K	0.01%	818
2024 Q1	$8.76M	Buy	100,279 +39,708	+66%	+$3.55M	0.01%	800
2023 Q4	$5.84M	Buy	60,571 +59,760	+7,369%	+$5.29M	0.01%	905
2023 Q3	$71.8K	Sell	811 -28,129	-97%	-$2.5M	﹤0.01%	2130
2023 Q2	$2.51M	Sell	28,940 -437,747	-94%	-$41.2M	﹤0.01%	1166
2023 Q1	$45.4M	Buy	466,687 +34,286	+8%	+$3.55M	0.08%	361
2022 Q4	$44.7M	Buy	432,401 +427,438	+8,612%	+$40.1M	0.08%	347
2022 Q3	$420K	Sell	4,963 -2,099	-30%	-$187K	﹤0.01%	1624
2022 Q2	$584K	Sell	7,062 -17,898	-72%	-$1.43M	﹤0.01%	1544
2022 Q1	$1.92M	Buy	24,960 +4,451	+22%	+$372K	﹤0.01%	1523
2021 Q4	$1.81M	Buy	+20,509	New	+$1.69M	﹤0.01%	1593